Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Integrin beta 2 antibody

This Human Monoclonal antibody specifically detects Integrin beta 2 in FACS. It exhibits reactivity toward Human.
Catalog No. ABIN7567397

Quick Overview for Integrin beta 2 antibody (ABIN7567397)

Target

See all Integrin beta 2 (ITGB2) Antibodies
Integrin beta 2 (ITGB2)

Reactivity

  • 197
  • 54
  • 44
  • 9
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 105
  • 91
  • 35
  • 2
  • 1
Human

Clonality

  • 135
  • 94
  • 2
Monoclonal

Conjugate

  • 107
  • 22
  • 20
  • 16
  • 8
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Integrin beta 2 antibody is un-conjugated

Application

  • 130
  • 89
  • 60
  • 46
  • 45
  • 33
  • 27
  • 26
  • 26
  • 26
  • 19
  • 16
  • 8
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS)

Clone

LDP-01
  • Purpose

    Anti-Human CD18/ITGB2 Antibody (LDP-01)

    Purification

    Protein A or G purified.

    Purity

    >95 %

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
  • Target

    Integrin beta 2 (ITGB2)

    Alternative Name

    CD18

    Background

    Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2

    Pathways

    NF-kappaB Signaling, Activation of Innate immune Response, Toll-Like Receptors Cascades, Activated T Cell Proliferation
You are here:
Chat with us!